Harvard Physician Targets Senior Cannabis Use in New Medical Guide

A Harvard Medical School physician has published a comprehensive guide aimed at seniors exploring cannabis as an alternative to traditional prescription medications.

Dr. Peter Grinspoon's "Aging Well with Cannabis" positions the plant as a potential solution for older adults struggling with polypharmacy—the use of multiple prescription drugs simultaneously. The book arrives as data shows Americans over 65 represent one of the fastest-growing demographics of cannabis users, with many seeking relief from chronic pain, insomnia, and inflammation without adding to their existing medication regimens.

"The senior population is dealing with an average of five to seven prescription medications," said Grinspoon, a primary care physician and cannabis specialist at Massachusetts General Hospital. "Cannabis offers a way to potentially reduce that burden while addressing multiple conditions with a single plant-based medicine."

The Numbers Behind Senior Cannabis Adoption

Market data supports the growing interest. A 2023 University of California study found cannabis use among adults 65 and older increased 75% between 2019 and 2022. Yet this demographic often lacks reliable medical guidance—most physicians receive little to no training in cannabis therapeutics during medical school.

Grinspoon's Harvard credentials lend institutional weight to a topic that's struggled for mainstream medical acceptance. The book provides dosing protocols, strain selection guidance, and drug interaction warnings specifically tailored to older adults who may be managing conditions like arthritis, neuropathy, or chemotherapy side effects.

The timing coincides with increased scrutiny of prescription opioid use in elderly populations. Federal data shows emergency room visits related to adverse drug reactions in seniors cost Medicare over $4 billion annually. Cannabis advocates argue the plant's safety profile—it's impossible to fatally overdose on THC—makes it a logical alternative for pain management.

Medical Community Response

The book has drawn attention from geriatric specialists looking for evidence-based cannabis resources. Dr. Grinspoon includes peer-reviewed research on cannabinoid interactions with common senior medications, from blood thinners to diabetes drugs—information largely absent from existing cannabis literature.

"We're seeing caregivers and adult children researching cannabis options for their parents," Grinspoon noted. "But they're finding Reddit threads instead of medical guidance. That's a problem we can solve."

The guide addresses practical concerns unique to older users: how cannabis affects balance and fall risk, interactions with heart medications, and whether edibles or tinctures work better for arthritic hands that struggle with vaporizers.

What's Next

Grinspoon's work arrives as several medical schools, including Harvard's own continuing education programs, have begun offering cannabis medicine courses. The American Geriatrics Society updated its position on medical cannabis in 2023, acknowledging its potential role in senior care while calling for more research.

The book's release could influence how primary care physicians approach cannabis conversations with older patients. With 38 states now offering medical marijuana programs and many including chronic pain and PTSD among qualifying conditions, seniors increasingly have legal access—but often lack medical support in using it safely.

For an industry that's spent years fighting stigma, having a Harvard-affiliated physician author a senior-focused cannabis guide represents a significant credibility milestone. The question now is whether other mainstream medical institutions will follow with their own evidence-based guidance.

This article is based on original reporting by hightimes.com.